Source comparison
Mechanisms: Stimulation vs Replacement
Sermorelin acetate is a 29-amino acid peptide that replicates the first 29 residues of endogenous GHRH. The full-length 44-amino acid hormone produced by the hypothalamus. When administered subcutaneously, sermorelin binds to GHRH receptors on somatotroph cell
This comparison does not assign a generated winner or score.
- Sermorelin acetate is a 29-amino acid peptide that replicates the first 29 residues of endogenous GHRH. The full-length 44-amino acid hormone produced by the hypothalamus. When administered subcutaneously, sermorelin binds to GHRH receptors on somatotroph cells in the anterior pituitary, triggering intracellular cyclic AMP production and calcium mobilisation, which culminates in the synthesis and pulsatile release of growth hormone into systemic circulation. Importantly, this release occurs in bursts that mirror natural GH secretion patterns. Highest during deep sleep and lowest during waking hours. Because sermorelin doesn't override the body's negative feedback loops. When GH levels rise, somatostatin (growth hormone-inhibiting hormone) is released from the hypothalamus to shut down further secretion until the next pulse cycle begins.
- HGH therapy delivers bioidentical recombinant human growth hormone. Typically somatropin. Manufactured through recombinant DNA technology in E. coli or mammalian cell lines. This is the 191-amino acid polypeptide hormone identical in structure to endogenous GH secreted by the pituitary. When injected, it enters circulation immediately and binds directly to GH receptors in target tissues. Liver, muscle, adipose, bone. Without requiring pituitary involvement. The result is steady-state hormone elevation rather than pulsatile bursts. Exogenous HGH bypasses somatostatin regulation entirely; the body cannot modulate circulating levels the way it does with endogenous secretion. Over time, chronic HGH administration suppresses the pituitary's own GH production through negative feedback on GHRH release. A form of secondary hypogonadism at the level of the somatotroph axis.
- The practical implication: sermorelin enhances what your pituitary still does. HGH replaces what it no longer does (or does insufficiently). If your pituitary retains functional somatotroph cells, sermorelin preserves physiological regulation. If your pituitary is compromised. Whether through damage, tumour, surgical resection, or congenital deficiency. HGH is the only option that bypasses the missing gland entirely.